ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 85 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,941,000 | -48.9% | 3,322,737 | -37.8% | 0.00% | -40.0% |
| Q1 2022 | $3,801,000 | -70.7% | 5,338,766 | -45.6% | 0.01% | -66.7% |
| Q4 2021 | $12,957,000 | -48.1% | 9,816,108 | -9.5% | 0.02% | -50.0% |
| Q3 2021 | $24,947,000 | -57.7% | 10,846,420 | -19.3% | 0.03% | -57.1% |
| Q2 2021 | $59,015,000 | -23.6% | 13,443,032 | +26.3% | 0.07% | -28.6% |
| Q1 2021 | $77,274,000 | +344.3% | 10,643,790 | +164.4% | 0.10% | +366.7% |
| Q4 2020 | $17,391,000 | +15.9% | 4,025,810 | +10.2% | 0.02% | 0.0% |
| Q3 2020 | $15,008,000 | -12.0% | 3,651,559 | +28.4% | 0.02% | -22.2% |
| Q2 2020 | $17,063,000 | -9.2% | 2,843,867 | +14.0% | 0.03% | -32.5% |
| Q1 2020 | $18,790,000 | -49.2% | 2,495,360 | -7.2% | 0.04% | -38.5% |
| Q4 2019 | $36,992,000 | +78.4% | 2,690,327 | +54.1% | 0.06% | +66.7% |
| Q3 2019 | $20,741,000 | -10.9% | 1,745,894 | +5.0% | 0.04% | -9.3% |
| Q2 2019 | $23,272,000 | – | 1,663,435 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |